prikaz prve stranice dokumenta Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19
  Download
PDF 322.57 KB
Scientific paper - Review paper
Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19
Liječnički vjesnik, 143 (2021), 11-12; 473-477. https://doi.org/10.26800/LV-143-11-12-9
Žiga, Sead; Andrić, Dejan; Jurić Banai, Sanja; Franjić, Kristina; Vujović, Dragan; Pleško, Eva; Ljubičić, Dživo; Piskač Živković, Nevenka; Banić, Marko

Linked objects
COVID-19 | Virtual collection

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Žiga, S., Andrić, D., Jurić Banai, S., Franjić, K., Vujović, D., Pleško, E. ... Banić, M. (2021). Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19. Liječnički vjesnik, 143. (11-12), 473-477. doi: 10.26800/LV-143-11-12-9

Žiga, Sead, et al. "Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19." Liječnički vjesnik, vol. 143, no. 11-12, 2021, pp. 473-477. https://doi.org/10.26800/LV-143-11-12-9

Žiga, Sead, Dejan Andrić, Sanja Jurić Banai, Kristina Franjić, Dragan Vujović, Eva Pleško, Dživo Ljubičić, Nevenka Piskač Živković and Marko Banić. "Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19." Liječnički vjesnik 143, no. 11-12 (2021): 473-477. https://doi.org/10.26800/LV-143-11-12-9

Žiga, S., et al. (2021) 'Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19', Liječnički vjesnik, 143(11-12), pp. 473-477. doi: 10.26800/LV-143-11-12-9

Žiga S, Andrić D, Jurić Banai S, Franjić K, Vujović D, Pleško E, and sur.. Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19. Liječnički vjesnik [Internet]. 2021 [cited 2024 November 22];143(11-12):473-477. doi: 10.26800/LV-143-11-12-9

S. Žiga, et al., "Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19", Liječnički vjesnik, vol. 143, no. 11-12, pp. 473-477, 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:567727. [Accessed: 22 November 2024]

Metadata
Title (croatian)Uloga hiperbarične oksigenoterapije (HBOT) u liječenju oboljelih od COVID-19
Title (english)The role of hyperbaric oxygenotherapy (HBOT) in the treatment of COVID-19 patients
AuthorSead Žiga
AuthorDejan Andrić
AuthorSanja Jurić Banai
AuthorKristina Franjić
AuthorDragan Vujović
AuthorEva Pleško
AuthorDživo Ljubičić
AuthorNevenka Piskač Živković
AuthorMarko Banić
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (croatian)
Pandemija COVID-19 postavila je velik izazov suvremenoj medicini. Unatoč značajnim naporima medicinske i znanstvene zajednice, do trenutka pisanja ovog članka i dalje ne postoji ciljano etiološko liječenje bolesnika akutno oboljelih od COVID-19, kao i bolesnika s post-COVID sindromom. Hiperbarična oksigenoterapija (HBOT) jest medicinski i znanstveno priznat terapijski postupak u liječenju brojnih akutnih i kroničnih stanja u kojima je nedostatak kisika osnovni patofiziološki poremećaj. S obzirom na nekoliko publiciranih serija slučajeva koji su pokazali značajan povoljni učinak primjene HBOT-a u liječenju pacijenata oboljelih od infekcije COVID-19 te na osnovi višedesetljetnog iskustva u primjeni HBOT-a u drugim poljima, rodila se potreba za provođenjem kvalitetnih i dobro strukturiranih studija kojima je cilj jasno ispitati utjecaj primjene HBOT-a u liječenju oboljelih od COVID-19. Prema dostupnim izvorima trenutno se u svijetu provodi 9 takvih istraživanja. Mehanizmi učinka primjene HBOT-a u liječenju oboljelih od COVID-19 zasnivaju se na korekciji hipoksije, atenuaciji upalnog odgovora te „otplate duga kisika“ u kratkom vremenskom razdoblju, na taj način osiguravajući prozor aerobnom metabolizmu u duboko hipoksičnim tkivima i važnim organima.
Abstract (english)
The COVID-19 pandemic has posed a major challenge to modern medicine. Despite significant efforts by the medical and scientific community, at the time of writing, there is still no targeted etiological treatment for acutely ill COVID-19 patients as well as patients with post-COVID syndrome. Hyperbaric oxygen therapy (HBOT) is a medically and scientifically recognized therapeutic procedure in the treatment of a number of acute and chronic conditions in which oxygen deficiency is pathophysiologically primary disorder. Given the several published series of cases that have shown a significant beneficial effect of HBOT in the treatment of patients with COVID-19 infection, and based on decades of experience in the use of HBOT in other fields, the need to conduct quality and well-structured studies arose with the aim to clearly examine the impact of HBOT use in the treatment of COVID-19 patients. According to available sources, nine such studies are being conducted worldwide.The mechanisms of the effect of HBOT in the treatment of COVID-19 patients are based on the correction of hypoxia, attenuation of the inflammatory response and “repayment of oxygen debt” in a short period of time, thus providing a window to aerobic metabolism in deeply hypoxic tissues and important organs.
Keywords (croatian)
Keywords (english)
Languagecroatian
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleLiječnički vjesnik
Numberingvol. 143, no. 11-12, pp. 473-477
p-ISSN0024-3477
e-ISSN1849-2177
DOIhttps://doi.org/10.26800/LV-143-11-12-9
URN:NBNurn:nbn:hr:105:567727
Publication2021
Document URLhttps://hrcak.srce.hr/269404
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-01-27 12:33:45